These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 26269187

  • 1. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M, Niittykoski M, von und zu Fraunberg M, Immonen A, Koponen S, van Geenen M, Vähä-Koskela M, Ylösmäki E, Jääskeläinen JE, Saksela K, Hinkkanen A.
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.
    Määttä AM, Liimatainen T, Wahlfors T, Wirth T, Vähä-Koskela M, Jansson L, Valonen P, Häkkinen K, Rautsi O, Pellinen R, Mäkinen K, Hakumäki J, Hinkkanen A, Wahlfors J.
    Int J Cancer; 2007 Aug 15; 121(4):863-70. PubMed ID: 17443493
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.
    Määttä AM, Mäkinen K, Ketola A, Liimatainen T, Yongabi FN, Vähä-Koskela M, Pirinen R, Rautsi O, Pellinen R, Hinkkanen A, Wahlfors J.
    Int J Cancer; 2008 Oct 01; 123(7):1704-11. PubMed ID: 18651570
    [Abstract] [Full Text] [Related]

  • 7. The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons.
    Fragkoudis R, Breakwell L, McKimmie C, Boyd A, Barry G, Kohl A, Merits A, Fazakerley JK.
    J Gen Virol; 2007 Dec 01; 88(Pt 12):3373-3384. PubMed ID: 18024907
    [Abstract] [Full Text] [Related]

  • 8. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ, Kallio JP, Jansson LC, Heikkilä JE, Zakhartchenko VA, Kallajoki MA, Kähäri VM, Hinkkanen AE.
    Cancer Res; 2006 Jul 15; 66(14):7185-94. PubMed ID: 16849565
    [Abstract] [Full Text] [Related]

  • 9. IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma.
    Martikainen M, Ramachandran M, Lugano R, Ma J, Martikainen MM, Dimberg A, Yu D, Merits A, Essand M.
    Mol Ther Oncolytics; 2021 Jun 25; 21():37-46. PubMed ID: 33869741
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. mRNA expression of proinflammatory cytokines in mouse CNS correlates with replication rate of semliki forest virus but not with the strain of viral proteins.
    Tuittila M, Nygårdas P, Hinkkanen A.
    Viral Immunol; 2004 Jun 25; 17(2):287-97. PubMed ID: 15279706
    [Abstract] [Full Text] [Related]

  • 15. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy.
    Elankumaran S, Chavan V, Qiao D, Shobana R, Moorkanat G, Biswas M, Samal SK.
    J Virol; 2010 Apr 25; 84(8):3835-44. PubMed ID: 20147405
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q, Wu J, Ye Q, Ma F, Zhu Q, Wu Y, Shan C, Xie X, Li D, Zhan X, Li C, Li XF, Qin X, Zhao T, Wu H, Shi PY, Man J, Qin CF.
    mBio; 2018 Sep 18; 9(5):. PubMed ID: 30228241
    [Abstract] [Full Text] [Related]

  • 17. A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus.
    Fazakerley JK, Boyd A, Mikkola ML, Kääriäinen L.
    J Virol; 2002 Jan 18; 76(1):392-6. PubMed ID: 11739703
    [Abstract] [Full Text] [Related]

  • 18. Semliki Forest virus nonstructural protein 2 is involved in suppression of the type I interferon response.
    Breakwell L, Dosenovic P, Karlsson Hedestam GB, D'Amato M, Liljeström P, Fazakerley J, McInerney GM.
    J Virol; 2007 Aug 18; 81(16):8677-84. PubMed ID: 17553895
    [Abstract] [Full Text] [Related]

  • 19. Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells.
    Walton RW, Brown MC, Sacco MT, Gromeier M.
    J Virol; 2018 Oct 01; 92(19):. PubMed ID: 29997212
    [Abstract] [Full Text] [Related]

  • 20. Semliki Forest virus vectors with mutations in the nonstructural protein 2 gene permit extended superinfection of neuronal and non-neuronal cells.
    Ehrengruber MU, Goldin AL.
    J Neurovirol; 2007 Aug 01; 13(4):353-63. PubMed ID: 17849319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.